Charles River Laboratories International (CRL) Competitors $163.76 -2.04 (-1.23%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Charles River Laboratories International (NYSE:CRL) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Do analysts recommend CRL or MTD? Charles River Laboratories International presently has a consensus target price of $209.00, indicating a potential upside of 27.62%. Mettler-Toledo International has a consensus target price of $1,351.25, indicating a potential upside of 4.28%. Given Charles River Laboratories International's higher possible upside, research analysts plainly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charles River Laboratories International 3 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.94Mettler-Toledo International 1 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.11 Which has higher valuation and earnings, CRL or MTD? Mettler-Toledo International has lower revenue, but higher earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCharles River Laboratories International$4.13B2.03$474.62M$7.9920.50Mettler-Toledo International$3.79B7.22$788.78M$37.0934.94 Which has more risk and volatility, CRL or MTD? Charles River Laboratories International has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Does the media refer more to CRL or MTD? In the previous week, Charles River Laboratories International had 11 more articles in the media than Mettler-Toledo International. MarketBeat recorded 22 mentions for Charles River Laboratories International and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.45 beat Charles River Laboratories International's score of 0.40 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 4 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Mettler-Toledo International 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in CRL or MTD? 98.9% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is CRL or MTD more profitable? Mettler-Toledo International has a net margin of 21.15% compared to Charles River Laboratories International's net margin of 10.44%. Charles River Laboratories International's return on equity of 14.29% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Charles River Laboratories International10.44% 14.29% 6.53% Mettler-Toledo International 21.15%-531.78%24.79% Does the MarketBeat Community believe in CRL or MTD? Charles River Laboratories International received 122 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 60.22% of users gave Charles River Laboratories International an outperform vote while only 56.75% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformCharles River Laboratories InternationalOutperform Votes49260.22% Underperform Votes32539.78% Mettler-Toledo InternationalOutperform Votes37056.75% Underperform Votes28243.25% SummaryMettler-Toledo International beats Charles River Laboratories International on 9 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$8.37B$4.14B$5.21B$19.94BDividend YieldN/A1.82%5.13%3.71%P/E Ratio20.5052.2789.1841.40Price / Sales2.0344.711,240.0416.25Price / Cash11.0723.2643.7519.84Price / Book2.333.335.315.76Net Income$474.62M$139.50M$122.54M$993.25M7 Day Performance-13.87%-0.36%0.59%3.12%1 Month Performance-11.85%-3.53%2.55%4.75%1 Year Performance-22.76%18.90%25.29%18.83% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.8235 of 5 stars$163.77-1.2%$209.00+27.6%-22.8%$8.37B$4.13B20.5021,800Analyst ForecastShort Interest ↑Analyst RevisionHigh Trading VolumeMTDMettler-Toledo International4.1592 of 5 stars$1,264.54+4.4%$1,351.25+6.9%+8.0%$26.69B$3.76B34.0918,000Positive NewsWATWaters4.3951 of 5 stars$400.42+5.3%$384.71-3.9%+29.3%$23.78B$2.91B38.217,900ILMNIllumina4.6387 of 5 stars$144.25+5.5%$165.63+14.8%+0.6%$22.88B$4.39B-14.489,300TECHBio-Techne4.0488 of 5 stars$75.89+3.5%$82.00+8.1%+7.8%$12.06B$1.17B80.733,100BIOBio-Rad Laboratories4.0851 of 5 stars$350.73+2.6%$394.20+12.4%+11.9%$9.82B$2.58B-12.838,030Short Interest ↑BRKRBruker4.9757 of 5 stars$63.08+3.8%$74.45+18.0%-20.9%$9.56B$3.24B30.338,520Analyst ForecastPACBPacific Biosciences of California2.1325 of 5 stars$2.00-4.8%$2.95+47.7%-75.1%$547.73M$173.15M-1.37730Gap UpHBIOHarvard Bioscience1.1674 of 5 stars$1.82-4.2%N/A-55.1%$79.38M$97.73M-5.51490News CoveragePositive NewsHigh Trading VolumeTMOThermo Fisher Scientific4.9785 of 5 stars$558.47+3.0%$650.52+16.5%+1.4%$213.61B$42.37B35.01122,000News CoveragePositive NewsAAgilent Technologies4.1635 of 5 stars$142.19+3.4%$143.62+1.0%+12.5%$40.61B$6.51B32.1718,100Short Interest ↓Positive News Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CRL) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts